Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway
Molecules · 08.01.2026 · 31 (2) · 219
DOI: 10.3390/molecules31020219 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 08.01.2026. Verfasst von Jingyuan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of National Forestry and Grassland Administration on Chinese Herbal Medicine, College of Life Science, Northeast Forestry University, …. Hauptthemen laut MEDLINE: Diterpenes, Neuroprotective Agents, Biosynthetic Pathways, Hericium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province of China, Natural Science Foundation of Shenzhen.
Abstract (Originalsprache)
Erinacine A, a cyathane diterpenoid derived from the medicinal and edible fungus Hericium erinaceus, is increasingly recognized for its potent neurotrophic and neuroprotective properties. It demonstrates significant therapeutic promise for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease, primarily by stimulating the synthesis of nerve growth factor (NGF). However, the clinical applicability of erinacine A is currently restricted by its low yield from natural sources and high production costs. This challenge has spurred significant research focused on optimizing its production. This review provides a comprehensive overview of the current advancements in the fermentation-based preparation of erinacine A, including both liquid and solid-state cultivation techniques. Furthermore, we summarize its diverse biological activities, spanning neuroprotection, anticancer, and anti-inflammatory effects, and detail the recent discoveries elucidating its complex biosynthetic pathway. This consolidated overview offers insights into strategies for enhancing its production and supports its ongoing development as a therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of National Forestry and Grassland Administration on Chinese Herbal Medicine, College of Life Science, Northeast Forestry University, Harbin 150040, China.
- State Key Laboratory of Utilization of Woody Oil Resource, Northeast Forestry University, Harbin 150040, China.
ORCID-Profile: Jingyuan Wang, Huan Liu, Chunlei Wang, Chengwei Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province of China
- Natural Science Foundation of Shenzhen
Zitieren
APA
Wang, J., Liu, H., Wang, C., & Liu, C. (2026). Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway. Molecules, 31(2), 219. https://doi.org/10.3390/molecules31020219
Vancouver
Wang J, Liu H, Wang C, Liu C. Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway. Molecules. 2026;31(2):219. doi:10.3390/molecules31020219
BibTeX
@article{Wang2026,
author = {Wang, Jingyuan and Liu, Huan and Wang, Chunlei and Liu, Chengwei},
title = {Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway},
journal = {Molecules},
year = {2026},
volume = {31},
number = {2},
pages = {219},
doi = {10.3390/molecules31020219}
}
EUVIMED